Is bluebird bio, Inc. (BLUE) a Buy, Sell, or Hold?
NASDAQ : BLUE
bluebird bio, Inc. — Analyst Ratings
$4.97 USD
$0 (0.0%)
- Volume
- 1.25M
- Average Volume
- 576.32K
- Market Capitalization
- $48.67M
- P/E Ratio
- -0.20
- Dividend Yield
- 0.00%
- Price Target
- $12.50
- Year High
- $28.60
- Year Low
- $3.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
Analyst Consensus Summary
Consensus Rating
N/A
37 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-60.2%
vs Current Price
Price Target
$12.50
Average TargetPrice Target Range
Lowest Target
$5.00
-0.6% DOWNSIDE
Average Target
$12.50
Median Estimate
Highest Target
$25.00
-80.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 37
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 14 | 19 | 4 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Gena Wang | $5 | $5.825 | 2022-08-22 10:49 AM | -14.2% |
| Wedbush | David Nierengarten | $10 | $2.88 | 2022-03-06 07:00 PM | 247.2% |
| J.P. Morgan | Cory Kasimov | $14 | $10.7 | 2021-11-18 07:00 PM | 30.8% |
| Berenberg Bank | Zhiqiang Shu | $11 | $11.68 | 2021-11-11 07:00 PM | -5.8% |
| Goldman Sachs | Salveen Richter | $10 | $10.7 | 2021-11-07 07:00 PM | -6.5% |
| Evercore ISI | Joshua Schimmer | $25 | $11.84 | 2021-09-12 08:00 PM | 111.1% |
| Canaccord Genuity | John Newman | $20 | $12.97 | 2021-08-09 08:00 PM | 54.2% |
| Stifel Nicolaus | Benjamin Burnett | $18 | $11.76 | 2021-08-08 08:00 PM | 53.1% |